After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Mineralys Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Mineralys Therapeutics Inc is $977.26M. A total of 1.31 million shares were traded on the day, compared to an average of 806.84K shares.
In the most recent transaction, Rodman David Malcom sold 11,365 shares of MLYS for 12.93 per share on Aug 13 ’25. After the transaction, the Chief Medical Officer now owns 92,891 company shares. In a previous transaction on Aug 13 ’25, Rodman David Malcom bought 11,365 shares at 12.93 per share.
Among the insiders who sold shares, Levy Adam Scott disposed of 59,925 shares on Jul 30 ’25 at a per-share price of $14.76. This resulted in the CFO and Secretary holding 132,934 shares of MLYS after the transaction. In another insider transaction, Levy Adam Scott sold 12,946 shares at $14.04 per share on Jul 28 ’25. Company shares held by the CFO and Secretary now total 193,666.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, MLYS has a high of $18.38 and a low of $8.24.
As of this writing, MLYS has an earnings estimate of -$0.65 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.51 per share and a lower estimate of -$0.74. The company reported an EPS of -$1.13 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MLYS’s latest balance sheet shows that the firm has $10.61M in Cash & Short Term Investments as of fiscal 2021. There were $4.50M in debt and $5.05M in liabilities at the time. Its Book Value Per Share was $4.77, while its Total Shareholder’s Equity was -$22.93M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MLYS is Buy with a score of 4.56.
